Research ArticleArticle
Open Access
Postmarketing Surveillance of the Safety and Effectiveness of Etanercept in Japan
TAKAO KOIKE, MASAYOSHI HARIGAI, SHIGEKO INOKUMA, KAZUHIKO INOUE, NAOKI ISHIGURO, JUNNOSUKE RYU, TSUTOMU TAKEUCHI, YOSHIYA TANAKA, HISASHI YAMANAKA, KOICHI FUJII, BRUCE FREUNDLICH and MICHIO SUZUKAWA
The Journal of Rheumatology May 2009, 36 (5) 898-906; DOI: https://doi.org/10.3899/jrheum.080791
TAKAO KOIKE
MASAYOSHI HARIGAI
SHIGEKO INOKUMA
KAZUHIKO INOUE
NAOKI ISHIGURO
JUNNOSUKE RYU
TSUTOMU TAKEUCHI
YOSHIYA TANAKA
HISASHI YAMANAKA
KOICHI FUJII
BRUCE FREUNDLICH
REFERENCES
- 1.↵U.S. Food and Drug Administration. MEDWatch Program. [Internet. Accessed February 6, 2009.] Available from: http://www.fda.gov/cder/handbook/medwatch.htm
- 2.↵
- Carleton B,
- Foerster V,
- Warren L,
- Smith MA
- 3.↵
- Furst DE,
- Breedveld FC,
- Kalden JR,
- et al
- 4.↵
- Ledingham J,
- Deighton C
- 5.↵
- 6.↵Innovations Report. Half of patients with active early rheumatoid arthritis achieved clinical remission. Innovations Report website [Internet. Accessed February 6, 2009.] Available from: http://www.innovationsreport.com/html/reports/medicine_health/report-95903.html
- 7.↵Japan College of Rheumatology. Introducing Japan College of Rheumatology (JCR). Japan College of Rheumatology website [Internet. Accessed February 6, 2009.] Available from: http://www.ryumachi-jp.com/english/index.html
- 8.↵
- 9.↵Northrup Grumman Corporation. MedDRA and the MSSO. Northrup Grumman Corporation website [Internet. Accessed February 6, 2009.] Available from: http://www.meddramsso.com/MSSOWeb/index.htm
- 10.↵ICH Steering Committee. ICH Harmonised Tripartite Guideline. Clinical safety data management: definitions and standards for expedited reporting. Pharmaceuticals and Medical Devices Agency website [Internet. Accessed February 6, 2009.] Available from: http://www.pmda.go.jp/ich/e/e2a_95_3_20e.pdf
- 11.↵
- van Gestel AM,
- Prevoo ML,
- van ’t Hof MA,
- van Rijswijk MH,
- van de Putte LB,
- van Riel PL
- 12.↵
- Prevoo ML,
- van ’t Hof MA,
- Kuper HH,
- van Leeuwen MA,
- van de Putte LB,
- van Riel PL
- 13.↵
- 14.
- Bernatsky S,
- Feldman D,
- Shrier I,
- et al
- 15.↵
- Donahue KE,
- Gartlehner G,
- Jonas DE,
- et al
- 16.↵
- van Riel PL,
- Taggart AJ,
- Sany J,
- et al
- 17.↵
- 18.↵
- 19.↵
- 20.
- Botha T,
- Ryffel B
- 21.
- 22.↵
- Long R,
- Gardam M
- 23.↵World Health Organization. Global tuberculosis control: surveillance, planning, financing: WHO Report 2007. World Health Organization website. [Internet. Accessed February 6, 2009.] Available from: http://www.who.int/tb/en/
- 24.↵
- 25.
- 26.↵
- van der Heijde D,
- Da Silva JC,
- Dougados M,
- et al
In this issue
The Journal of Rheumatology
Vol. 36, Issue 5
1 May 2009
Postmarketing Surveillance of the Safety and Effectiveness of Etanercept in Japan
TAKAO KOIKE, MASAYOSHI HARIGAI, SHIGEKO INOKUMA, KAZUHIKO INOUE, NAOKI ISHIGURO, JUNNOSUKE RYU, TSUTOMU TAKEUCHI, YOSHIYA TANAKA, HISASHI YAMANAKA, KOICHI FUJII, BRUCE FREUNDLICH, MICHIO SUZUKAWA
The Journal of Rheumatology May 2009, 36 (5) 898-906; DOI: 10.3899/jrheum.080791
Postmarketing Surveillance of the Safety and Effectiveness of Etanercept in Japan
TAKAO KOIKE, MASAYOSHI HARIGAI, SHIGEKO INOKUMA, KAZUHIKO INOUE, NAOKI ISHIGURO, JUNNOSUKE RYU, TSUTOMU TAKEUCHI, YOSHIYA TANAKA, HISASHI YAMANAKA, KOICHI FUJII, BRUCE FREUNDLICH, MICHIO SUZUKAWA
The Journal of Rheumatology May 2009, 36 (5) 898-906; DOI: 10.3899/jrheum.080791